Patent details

EP1682542 Title: NOVEL CRYSTALLINE ANHYDRIDE WITH ANTICHOLINERGIC EFFECT

Basic Information

Publication number:
EP1682542
PCT Application Number:
PCT/EP/2004/012269
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047910294
PCT Publication Number:
WO/2005/042527
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
NOVEL CRYSTALLINE ANHYDRIDE WITH ANTICHOLINERGIC EFFECT
French Title of Invention:
NOUVEL ANHYDRATE CRISTALLIN A EFFET ANTICHOLINERGIQUE
German Title of Invention:
NEUES KRISTALLINES ANHYDRAT MIT ANTICHOLINERGER WIRKSAMKEIT
SPC Number:

Dates

Filing date:
29/10/2004
Grant date:
30/12/2009
EP Publication Date:
30/12/2009
PCT Publication Date:
12/05/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/07/2006
EP B1 Publication Date:
30/12/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/10/2022
Expiration date:
29/10/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/10/2004
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
PFRENGLE Waldemar
Address:
Germany (DE)

2

Name:
SIEGER Peter
Address:
Germany (DE)

Priority

Priority Number:
03025077
Priority Date:
03/11/2003
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 451/10;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
20/10/2021
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages